4//SEC Filing
Breen Michael Martin 4
Accession 0001641172-25-026890
CIK 0000109657other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 5:45 PM ET
Size
10.1 KB
Accession
0001641172-25-026890
Insider Transaction Report
Form 4
Breen Michael Martin
Director
Transactions
- Award
Option to purchase Common Stock
2025-09-04+100,000→ 100,000 totalExercise: $1.33Exp: 2035-08-19→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]The options are fully vested and exercisable.
- [F2]The option vests in four equal quarterly installments beginning on January 1, 2025.
- [F3]The option vests in four equal quarterly installments beginning on January 1, 2026.
Documents
Issuer
GT Biopharma, Inc.
CIK 0000109657
Entity typeother
Related Parties
1- filerCIK 0001863633
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 5:45 PM ET
- Size
- 10.1 KB